Literature DB >> 2222049

Complement activation and lung permeability during cardiopulmonary bypass.

S D Tennenberg1, C W Clardy, W W Bailey, J S Solomkin.   

Abstract

Pulmonary dysfunction after cardiopulmonary bypass has been attributed to the damaging effects of complement activation on the lung. To further explore this phenomenon, we measured plasma levels of activated complement components (radioimmunoassay), assessed neutrophil n-formyl-methionyl-leucyl-phenylalanine (FMLP) receptor status (radioligand saturation binding assay), and quantified pulmonary epithelial permeability as radioaerosol lung clearance of technetium 99m-labeled diethylenetriamine pentaacetic acid in a series of 8 patients undergoing cardiopulmonary bypass. Significant elevations of plasma C3adesArg, C4adesArg, and C5adesArg levels were seen just after CPB, indicating activation of both the classic and alternate complement pathways. Neutrophil activation was evident as increased expression of neutrophil FMLP surface receptors after bypass. Despite the presence of complement and neutrophil activation, increased pulmonary epithelial permeability was not seen. These data support the hypothesis that complement and neutrophil activation during cardiopulmonary bypass is not associated with acute lung injury, at least not pulmonary epithelial injury. One can therefore infer that increased pulmonary epithelial permeability in patients at high risk for and experiencing sepsis-induced and trauma-induced adult respiratory distress syndrome may be due to factors other than complement and neutrophil activation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2222049     DOI: 10.1016/0003-4975(90)90196-d

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  7 in total

1.  The superiority of pulmonary function after minimally invasive direct coronary artery bypass.

Authors:  Akihiko Ohkado; Kiyoharu Nakano; Hayao Nakatani; Akihiko Gomi; Noboru Sugiyama; Naoki Saegusa
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-02

Review 2.  Lung inflammatory response syndrome after cardiac-operations and treatment of lornoxicam.

Authors:  Kosmas Tsakiridis; Andreas Mpakas; George Kesisis; Stamatis Arikas; Michael Argyriou; Stavros Siminelakis; Paul Zarogoulidis; Nikolaos Katsikogiannis; Ioanna Kougioumtzi; Theodora Tsiouda; Eirini Sarika; Ioanna Katamoutou; Konstantinos Zarogoulidis
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

3.  Severe pulmonary vascular change in patients dying with right ventricular failure after heart transplantation.

Authors:  P S Hasleton; N H Brooks
Journal:  Thorax       Date:  1995-02       Impact factor: 9.139

4.  Effect of PAF on polyrnorphonuclear leucocyte plasma membrane polarity: a fluorescence study.

Authors:  A Kantar; P L Giorgi; R Fiorini
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

5.  High postoperative serum levels of surfactant type B as novel prognostic markers for congenital heart surgery.

Authors:  Onur IsiK; Olcay Murat Disli; Tolga Bas; Hakan AydiN; Murat Koç; Ali Kutsal
Journal:  Rev Bras Cir Cardiovasc       Date:  2014 Apr-Jun

6.  Complement activation by recombinant adenoviruses.

Authors:  G Cichon; S Boeckh-Herwig; H H Schmidt; E Wehnes; T Müller; P Pring-Akerblom; R Burger
Journal:  Gene Ther       Date:  2001-12       Impact factor: 5.250

7.  NPC 15669 blocks neutrophil CD18 increase and lung injury during cardiopulmonary bypass in pigs.

Authors:  J M Bator; A M Gillinov; K J Zehr; J M Redmond; I C Wilson; A Herskowitz; J R Connor; R M Burch; D E Cameron
Journal:  Mediators Inflamm       Date:  1993       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.